COVID-19 continues to be a challenge for the blood cancer community, creating anxiety and isolation.
LLSC continues to monitor the situation and to advocate in an ongoing manner so that the specific needs of the blood cancer community are not forgotten.
Highlights of our advocacy activities
Letter to NACI on the need to update conditions considered to be moderately to severely immunocompromised
International COVID-19 blood cancer coalition Patients impact statement and recommendations
Letter to Health Canada, NACI, provincial health ministers, premiers, cancer agencies on behalf of 27 clinicians and 6 organizations regarding prioritization and access to vaccine